Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
PT-141 (alternatively, bremelanotide) is a synthetic cyclic heptapeptide that emulates the function of -melanocyte stimulating hormone (alpha-MSH), a hormone mainly secreted by the pituitary gland [1]
Talk to us first if you Are pregnant or breastfeeding Have a known allergy to an ingredient Have kidney disease (for some shots) Take medications that may interact Have a bleeding disorder This is general information, not medical advice
The symptom is not listed in MHRA-approved product documentation or clinical trial data
The protocol was approved by the Central Adelaide Local Health Network Human Research Ethics Committee (reference number: 2021/HRE00130), and prospectively registered in the Australian New Zealand Clinical Trials Registry (ACTRN12621000878875)
US$ 29.51
US$ 25.67
US$ 28.18
US$ 28.62
US$ 24.81
US$ 22.75
